Loading...
01/11 17:36
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights several concerns: a significant revenue decline, increased net debt, and cash flow issues due to shorter payment terms. Although there are positive developments like resumed orders from a large retailer and cost management measures, the lack of guidance and ongoing economic uncertainty overshadow these positives. The Q&A session did not alleviate concerns, especially regarding tariffs and financial pressures. These factors suggest a negative market reaction, likely leading to a stock price decline between -2% and -8% over the next two weeks.
Total Revenue $132.8 million, down 15.2% year-over-year. The decline was primarily driven by lower volumes in the U.S. consumer business, reflecting overall softness in consumer demand and timing of retailer purchases.
Gross Profit $28 million or 21.1% of total revenue, compared to $43.9 million or 28% in the year-ago period. The decline was due to onetime incremental tariff costs of $5 million and a delay between tariff-related rising costs and pricing adjustments.
Selling, General and Administrative Expenses $25.1 million or 18.9% of total revenue, down from $33.3 million or 21.2% of total revenue in the third quarter of 2024. The decrease was driven by $6.8 million of lower personnel costs, including reduced stock-based compensation expense and benefits from restructuring actions.
Operating Profit $2.9 million or 2.2% of total revenue, compared to $10.6 million or 6.8% of total revenue in the third quarter of 2024. The decline was due to the temporary impact on gross margins from the peak tariff rate.
Net Income $1.7 million or $0.12 per diluted share, compared to $1.9 million or $0.14 per diluted share a year ago. The slight decline reflects the impact of tariff costs and other factors.
Net Cash Used for Operating Activities $14.6 million for the 9 months ended September 30, 2025, compared to net cash provided of $35.2 million for the same period in 2024. The decrease was due to a $27.5 million change in accounts payable, lower purchasing activity, and shorter payment terms with new suppliers.
Net Debt Position $32.8 million as of September 30, 2025, compared to $22.5 million at the end of the prior year period. The increase reflects changes in cash flow and debt management.
New product launches: Hamilton Beach Brands launched a high-end Lotus brand, which exceeded expectations with strong double-digit sell-through results. They also introduced new products in high-growth categories like blender kitchen systems, specialty coffee, and air fryers. Additionally, the HealthBeacon Harmony software product was launched with Novartis Ireland.
Market expansion: The company expanded its core business by shipping the 'kitchen collections by Hamilton Beach' line to a leading mass market retailer nationwide. The Lotus brand is being positioned for broader market reach with increased shelf space. The commercial business is focusing on new channel penetration and expanding relationships with large food and hospitality chains. The Health division achieved a milestone with a new specialty pharmacy partnership with CenterWell and Lumisir.
Operational efficiencies: The company implemented comprehensive cost management measures, generating $10 million in annualized savings. They diversified their manufacturing base away from China to other APAC countries, enabling flexibility in procurement. Digital improvements in the Health division resulted in a smoother patient experience, lower acquisition costs, and higher conversion rates.
Strategic shifts: Hamilton Beach Brands accelerated manufacturing diversification efforts away from China due to tariff impacts. They implemented pricing adjustments aligned with tariff rate increases and focused on maintaining competitive market positioning. The company emphasized digital growth to capitalize on the holiday shopping season.
Tariff Costs and Trade Environment: The company faced significant disruption due to higher tariffs implemented in April 2025, leading to $5 million in onetime incremental tariff costs and a temporary compression of gross profit margins. Although the peak tariff rate impact is now behind, the trade environment remains dynamic and uncertain.
Consumer Demand and Retailer Behavior: Lower volumes in the U.S. consumer business were driven by overall softness in consumer demand and delayed orders from a large retailer during the third quarter. Retailers paused buying in the second quarter to assess inventory levels and price increases, which negatively affected volumes in the early part of Q3.
Supply Chain and Manufacturing Diversification: Efforts to diversify manufacturing away from China to other APAC countries have been accelerated, but the transition has led to shorter payment terms with new suppliers, impacting cash flows. Inventory constraints also limited performance in the commercial business.
Economic Uncertainty and Market Conditions: Uncertainty in the marketplace persists, which could impact the company's ability to recover top-line growth and margins. The company acknowledges that its recovery in 2026 may not be linear.
Cost Management and Financial Pressures: The company has implemented cost management measures, but net cash used for operating activities was $14.6 million for the first nine months of 2025, compared to net cash provided of $35.2 million in the same period of 2024. This was primarily due to changes in accounts payable and lower purchasing activity.
Gross Margins: The company expects gross margins to normalize in future periods as the temporary compression caused by tariff-related rising costs and pricing adjustments is resolved.
Product Pipeline: The company has a robust pipeline of new products in high-growth categories such as blender kitchen systems, specialty coffee, and air fryers, which are expected to drive further market share gains.
Premium Business Expansion: The Lotus brand is performing above expectations, and the company is negotiating for increased shelf space to broaden market reach. Additional innovative launches are planned across CHI and Clorox brand partnerships in the coming quarters.
Commercial Business Growth: The company plans to accelerate commercial business expansion through new channel penetration and stronger relationships with large food and hospitality chains. Diversification of the manufacturing base for the commercial line is also underway to capture growing market opportunities.
Health Division Growth: Hamilton Beach Health achieved positive operating profit for the first time. New partnerships with CenterWell and Lumisir, as well as the launch of HealthBeacon Harmony software with Novartis Ireland, are expected to drive further growth. The division is also expanding its patient subscription base and improving digital capabilities.
Digital Growth: The company is emphasizing digital growth in Q4 to capitalize on the holiday shopping season, following strong performance during a major digital retail event.
Fourth Quarter Expectations: The company anticipates further top-line and margin recovery in Q4, supported by brand strength, sourcing diversification, and pricing actions.
2026 Annual Performance: The company expects annual performance in 2026 to benefit from actions taken in 2025, including sourcing diversification and cost base reduction.
Dividends Paid: During the 3 months ended September 30, 2025, the company paid $1.6 million in dividends.
Share Repurchase: During the 3 months ended September 30, 2025, the company repurchased approximately 39,000 shares totaling $0.6 million.
The earnings call highlights several concerns: a significant revenue decline, increased net debt, and cash flow issues due to shorter payment terms. Although there are positive developments like resumed orders from a large retailer and cost management measures, the lack of guidance and ongoing economic uncertainty overshadow these positives. The Q&A session did not alleviate concerns, especially regarding tariffs and financial pressures. These factors suggest a negative market reaction, likely leading to a stock price decline between -2% and -8% over the next two weeks.
The earnings call reveals several concerns: a significant revenue decline, increased net debt, and cash flow issues. Although there are positive aspects like improved gross margins and strategic initiatives, the suspension of guidance due to tariff unpredictability and the lack of clear growth projections weigh heavily. Share repurchases and cost-saving measures are positive, but the overall financial performance and uncertainties suggest a negative sentiment. The Q&A section confirms these concerns, with management avoiding direct answers on growth alignment with GDP, further justifying a negative outlook.
The earnings call presents a mixed outlook. Financial performance shows improvement with revenue and profit growth, but the suspension of guidance due to tariff and economic uncertainties raises concerns. The Q&A reveals management's cautious stance on margins and retailer relations. Positive factors include debt reduction and shareholder returns through dividends and buybacks. However, the lack of guidance and market competition pressures balance these positives, suggesting a neutral stock price reaction in the near term.
The earnings call reflects mixed signals: strong financial performance with revenue and net income growth, but offset by declining margins and increased operational costs. The optimistic guidance and shareholder returns are positives, but supply chain challenges, competitive pressures, and management's vague responses in the Q&A section raise concerns. Without a market cap, the prediction assumes moderate reaction, resulting in a neutral outlook (-2% to 2%).
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
